Related Experiment Video
Updated: May 7, 2026

A Proteoliposome-Based Efflux Assay to Determine Single-molecule Properties of Cl- Channels and Transporters
Published on: April 20, 2015
Straight talk with...Daniel Levy. Interviewed by Elie Dolgin
Insights
The Framingham Heart Study, a vital cardiovascular disease research program, faces significant budget cuts due to sequestration. These funding reductions impact its long-term contract and necessitate staff layoffs.
Area of Science:
- Cardiovascular Disease Research
- Biomedical Science
- Public Health Funding
Background:
- The Framingham Heart Study (FHS) has been a cornerstone of cardiovascular disease research for over 65 years.
- It has provided critical insights into hypertension, stroke, and cardiac arrhythmias.
- FHS research is funded by the National Heart, Lung, and Blood Institute (NHLBI).
Discussion:
- The study's contract from the NHLBI, typically around $9 million annually, faced a $4 million reduction due to US government sequestration.
- The contract renewal is shortened from seven to two or three years.
- These financial constraints have led to 19 staff layoffs within the FHS.
Key Insights:
- Sequestration significantly impacts long-term biomedical research funding.
- Budgetary challenges can disrupt established research programs and their operations.
- The FHS, despite its historical significance, is not immune to economic pressures.
Outlook:
- Future research continuity and scope may be affected by reduced funding.
- The study's leadership is adapting to new financial realities.
- The long-term implications for cardiovascular disease research remain a concern.
Abstract:
The Framingham Heart Study (FHS) has long been a beacon of biomedical research, yielding landmark findings on everything from the links between elevated blood pressure and stroke to the genetic risk factors underlying cardiac arrhythmias. Now, the fabled 65-year-long study of cardiovascular disease is the beacon of a more modern trend in science: tight budgets. Thanks to the automatic cuts in US government spending known as sequestration, the approximately $9-million-per-year contract the FHS receives from the US National Heart, Lung, and Blood Institute (NHLBI) was reduced by $4 million on 1 August. The renewal of the contract, scheduled for 2015, is expected to run for only two or three years, instead of the usual seven as it has been in the past. And next month, the most visible effects of the cuts will take hold, when 19 layoffs (out of a total of 90 total staff members) go into effect. Overseeing the budget-related turbulence is Daniel Levy, a medical officer at the NHLBI who joined the FHS nearly 30 years ago and has served as the study's director since 1994. Elie Dolgin met with Levy in Framingham, on the outskirts of Boston, to discuss how he's taking the new funding realities to heart.
Related Concept Videos
The Bell Curve
This pattern applies to many human characteristics beyond intelligence, such as height. For example, if you...
Diffusion
Diffusion
The DNA Helix
The DNA Helix
The DNA Helix

